Classification ![]() |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (source: FDA (2003)) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7689 | abarelix |
Synonyms ![]() |
| Plenaxis® |
| PPI 149 |
| R 3827 |
Database Links ![]() |
|
| BindingDB Ligand | 50102442 |
| CAS Registry No. | 183552-38-7 (source: DrugBank) |
| ChEBI | CHEBI:337298 |
| ChEMBL Ligand | CHEMBL1252 |
| DrugBank Ligand | DB00106 |
| PharmGKB Drug | PA164754915 |
| PubChem CID | 16131215 |
| Search Google for chemical match using the InChIKey | AIWRTTMUVOZGPW-HSPKUQOVSA-N |
| Search Google for chemicals with the same backbone | AIWRTTMUVOZGPW |
| Search PubMed clinical trials | abarelix |
| Search PubMed titles | abarelix |
| Search PubMed titles/abstracts | abarelix |
| Wikipedia | Abarelix |
| Comments |
| Abarelix is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist. |